American Herbal Products Association (AHPA) > News > Alerts

FDA solicits comments on use of "natural" on food labeling (FDA)

AHPA Legal Alert

In response to four Citizen Petitions and the evolution of food ingredients, the Food and Drug Administration (FDA) is soliciting comments on the use of the term "natural" on food labeling.

FDA warns Orgen Nutraceuticals for online therapeutic claims (FDA)

AHPA Legal Alert

FDA sent this warning letter to Orgen Nutraceuticals for website claims that promote the company's supplement products for uses that cause the products to be drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease.

FDA warns Biomedic Labs for online drug claims (FDA)

AHPA Legal Alert

FDA warns Biomedic Labs for online claims that promote supplements for conditions that cause the products to be drugs.

Structural determinants for the pro-osteogenic activity of flavonoids (J Nat Prod)

AHPA Science Alert

Using comparative molecular field analysis, the authors identified structural features that relate to flavonoids activity on the osteogenic differentiation of human mesenchymal stem cells in vitro.

Flavones as a promising therapeutic target for cancer treatment (J Nat Prod)

AHPA Science Alert

Three flavones exhibited cellular inhibition of the AKR1B10-mediated reduction of the chemotherapeutic drug daunorubicin, without a considerable cytotoxic effect.

Orodispersible films for iodine deficiency in pediatric population (J Agric Food Chem)

AHPA Science Alert

In this study, a novel, ultra-rapidly dissolving, nanofiber-based, oral-dispersible film formulation containing iodine is described.

Former FDA official calls for new regulatory framework for dietary supplements

Editor's Note: Former FDA official Joshua Sharfstein is calling for a new regulatory framework for dietary supplements. In an article published in Drug Testing and Analysis, Sharfstein and his co-author, Akshay Kapoor, allege that the regulation of dietary supplements has not kept up with changes and risks in the market, which has ultimately led to policy gridlock. He proposes a conceptual shift from 'benefit versus risk' to 'access with safety,' which includes registration of all dietary supplements, a disclaimer on the limited role of FDA in evaluating product claims, standardized laboratory techniques, and clearer authority for the agency when safety concerns arise.

FDA warns Sound Healing Arts for drug claims and inadequate responses to alleged cGMP violations (FDA)

Editor's Note: FDA warns Sound Healing Arts for therapeutic claims online and product labels that establish products as drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease. FDA also warns to company for labeling violations, including failure to present nutrition information using the title "Supplement Facts" enclosed in a box. In addition, FDA warns the company for inadequate responses to alleged cGMP violations because the company failed to provide sufficient details about corrective actions being taken to ensure cGMP compliance.

Effects of Rhodiola rosea on mood symptoms (Phyto Res)

Editor's Note: In a non-placebo controlled trial, a specific product containing Rhodiola rosea extract demonstrated a significant reduction in self-reported anxiety, stress, anger, confusion and depression at 14 days and significant improvements in total mood. No relevant differences in cognitive performance were observed between the control and treatment groups.

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (JAMA)

Editor's Note: This review and analysis of cannabinoids for medical use found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term adverse events.
   

RSS
First 45678910111213 Last

 Looking for Something?

 Click on these links to see a filtered list of alerts in one of these four topic areas

 

 


2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.